Remove 2030 Remove Compounding Remove Medical Records
article thumbnail

AmerisourceBergen aims to make digital therapeutics access easier

pharmaphorum

AmerisourceBergen notes that the US market for DTx is predicted to grow at a compound annual growth rate of nearly 25% between 2022 to 2030, according to figures from Grand View Research which valued the category at $4.2 billion in 2021.